IP Library Assignment 041651/0413
Patent Assignment
Reel/Frame 041651/0413

Transformed

Recorded: 2017-02-07 Pages: 2
Assignor
VU-VUMC B.V.
Executed: 2011-12-31
Assignee
STICHTING VU-VUMC
DE BOELELAAN 1105, AMSTERDAM, 1081 HV, NETHERLANDS
Covered Property (1)
Protection Against Endothelial Barrier Dysfunction Through Inhibition of the Tyrosine Kinase Abl-Related Gene (Arg)
Patent: 9,290,765 →
Application: 14/115,279 →
Publication: US 2014/0187605
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2014
From: VAN NIEUW AMERONGEN, GEERTEN P.; VONK NOORDEGRAAF, ANTON; AMAN, JURJAN; VAN HINSBERGH, VICTOR W.M.
To: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG
Reel/Frame 032176/0058 →
Demerger Feb 7, 2017
From: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG
To: VU-VUMC B.V.
Reel/Frame 041651/0398 →
Change of Name Feb 7, 2017
From: STICHTING VU-VUMC
To: STICHTING VU
Reel/Frame 041651/0624 →
Demerger Feb 7, 2017
From: STICHTING VU
To: STICHTING VUMC
Reel/Frame 041651/0753 →
Merger and Change of Name Apr 19, 2024
From: ACADEMISCH MEDISCH CENTRUM; STICHTING VUMC
To: STICHTING AMSTERDAM UMC
Reel/Frame 067172/0001 →